产品名称
钐, foil, 50x50mm, thickness 0.1mm, as rolled, 99%
InChI
1S/Sm
SMILES string
[Sm]
InChI key
KZUNJOHGWZRPMI-UHFFFAOYSA-N
assay
99%
form
foil
manufacturer/tradename
Goodfellow 255-294-07
resistivity
91.4 μΩ-cm, 0°C
size × thickness
50x50 mm × 0.1 mm
bp
1794 °C (lit.)
mp
1074 °C (lit.)
density
7.47 g/mL at 25 °C (lit.)
正在寻找类似产品? 访问 产品对比指南
General description
For updated SDS information please visit www.goodfellow.com.
Legal Information
Product of Goodfellow
signalword
Warning
hcodes
Hazard Classifications
Water-react 3
存储类别
4.3 - Hazardous materials which set free flammable gases upon contact with water
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
监管及禁止进口产品
此项目有
Samarium(II)-iodide-mediated cyclizations in natural product synthesis.
David J Edmonds et al.
Chemical reviews, 104(7), 3371-3404 (2004-07-15)
Michal Szostak et al.
Chemical communications (Cambridge, England), 48(3), 330-346 (2011-09-01)
Samarium diiodide (SmI(2)) is one of the most important reductive electron transfer reagents available in the laboratory. Key to the popularity of SmI(2) is the ability of additives and co-solvents to tune the properties of the reagent. Over the last
Pete Anderson et al.
Expert review of anticancer therapy, 7(11), 1517-1527 (2007-11-21)
Radiation therapy can be an effective means to treat bone metastases, which occur in more than 50% of cancer patients. (153)Samarium lexidronam ((153)Sm-EDTMP; Quadramet, Cytogen) is a radiopharmaceutical designed for deposition into bone metastases. Bone scans can identify patients that
Masakazu Sono
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 123(8), 653-663 (2003-08-23)
Samarium (II) iodide has been employed to promote the vinylogous pinacol coupling reaction of aldehyde to alpha, beta-unsaturated ketones. The diastereoselectivity of 6-endo-trig mode products was changed by the addition of a proton source and/or HMPA and by the reaction
Pete Anderson
Expert opinion on pharmacotherapy, 7(11), 1475-1486 (2006-07-25)
Samarium-153 lexidronam (153Sm-EDTMP) is FDA approved for painful osteoblastic bone metastases that image on bone scan. 153Sm-EDTMP decay has a therapeutic beta-emission and a gamma-photon for bone scan imaging. Monitoring of osteosarcoma radiation treatment effectiveness was performed with bone, CT
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持